The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Efficacy of Xuezhikang Capsule and Atorvastatin on Blood Lipids in Patients with Unstable Angina Pectoris
Author(s): 
Pages: 914-916
Year: Issue:  7
Journal: Research of Traditional Chinese Medicine

Keyword:  unstable angina pectorisXuezhikang capsuleatorvastatin;
Abstract: Objective To observe the clinical efficacy of Xuezhikang capsule(XZKC)and atorvastatin on blood lipids in patients with unstable angina pectoris(UAP).Methods Sixty-two patients with UAP were selected and randomly divided into two groups:Control group(n =31)treated by routine treatment and atorvastatin,and treatment group(n =31)treated by routine treatment,atorvastatin and XZKC for 12 weeks.The blood lipid levels,the efficacy of medicine,acute cardiac events and adverse reactions were observed.Results After the treatment,the levels of total cholesterol(TC)and low density lipoprotein-eholesterol(LDL-C)in treatment group were significantly lower than those in control group(P <0.05).The total effective rate in treatment group was 93.5%,which was significantly higher than that in control group(P <0.05).The acute cardiac events and adverse reactions of medicine in treatment group were significantly lower than that in control group(P <0.05).Conclusion The curative effect of XZKC and atorvastatin is better than atorvastatin in patients with UAP,which can further improve the level of blood lipids and angina symptoms,reduce the incidence of cardiac event,and has good safety.
Related Articles
No related articles found